Vireo Growth Inc.
Last · OTC Markets OTCQX$9.11+0.16 (+1.79%)close · yahoo · 13h ago
Vol 13.9K ≈ 126.5K
MA10MA20MA50
Market cap$476.60M51.5M sh
P/E · TTM-5.3fwd 4.7 · eps -1.74 · loss
Beta0.17vs S&P 500
Div yield0.00%annual · TTM
52w range
$8.77$21.84
Volume13.9Ksession
Issuer
Legal nameVireo Growth Inc.
HQUnited States (US)
ListingUS VREO
SectorHealthcare
IndustryDrugs (Pharmaceutical)
SIC2834
CurrencyUSD
Entity registrysec:0001771706
CIK0001771706
Websitevireogrowth.com
| Revenue | $268.8M |
|---|---|
| Operating income | $-1.0M |
| Net income | $-68.1M |
| Free cash flow | $-24.6M |
| Operating margin | -0.4% |
| Net margin | -25.3% |
| Return on equity | -22.2% |
| Period | 2025 |
Loading chart…
OpenFilings analyst
Our analyst
10-K · 2026-03-17
From latest 10-K · 2026-03-17
- Net Margin Sharply Negative
Red flags
- Net Margin Sharply Negative — Net margin -25.3%
Upcoming earnings
WED.11NOV
1:30 PM UTC+1
Period
Sep 2026
Est. EPS
$0.36
Est. revenue
229.5M
Earnings transcripts
- Issuer webcast
Q4 2020 earnings call transcript
Vireo Growth Inc.
- Issuer webcast
Q4 2025 earnings call transcript
Vireo Growth Inc.
- Issuer webcast
Q3 2025 earnings call transcript
Vireo Growth Inc.
- Issuer webcast
Q1 2025 earnings call transcript
Vireo Growth Inc.
- Issuer webcast
Q4 2024 earnings call transcript
Vireo Growth Inc.
- Issuer webcast
Q2 2024 earnings call transcript
Vireo Growth Inc.
Documents
FormReporting forFiledFlags
Showing 5 of 169 filings